A purple and pink letter v on a white background.
June 16, 2017

How to Streamline Medical Aesthetic Patient Intake Forms

As a business professional, you know first impressions really matter. While you may put in the work to ensure your medical aesthetics clinic is welcoming and your staff are attentive to new patients the moment they walk through the door, you may be forgetting the one step new patients always dread: Long intake forms.

A necessity to your clinic but a tedious pain to your patients, intake forms can undo the positive first impression you’ve had on new prospects to this point. While patients understand that intake forms are a requirement when they visit any new medical aesthetics clinic, making the process run a little smoother for them could make all the difference to your conversion rate.

Luckily, we have five ideas you can use to improve your patient intake form process that patients will appreciate for their ease and convenience.

1. Take It Online

Making intake forms available on your website so prospective patients can fill them out in advance at their convenience is one simple and cost-effective way to improve your patient intake form process. Create a form using the same branding and design considerations of your website and make it available to print off from your website. Add a link in your main menu or add a clearly labeled button that prospects can easily find to download the forms. Save the form itself in .pdf format to ensure your formatting isn’t altered regardless of the device the patient uses to view it. This will also allow many of your clients to type their information into the forms, provided they have the right software, making the process even easier for your staff.

2. Opt for E-mail

In combination with your online intake forms, prompt your potential prospects to e-mail their completed forms to you prior to their appointment. By doing so, you eliminate the concern of forms being left at home. Further, it will allow your staff more time to review the information and follow up with the patient if needed prior to his or her first appointment.

3. Get Digital

While it requires a larger initial investment, consider replacing paper intake forms and clipboards in your reception area with tablets. Offering this digital option saves prospects’ time by allowing them to type in information and edit as needed without scratching out their errors or having to start all over again with fresh paper forms. It also saves your staff the hassle of digitizing the forms by having to manually type everything in. For a little fun and to cut down on potential patient boredom, you may also have your staff invite patients to use the tablet while they wait for browsing the Internet or checking social media after they’ve completed their forms.

4. Only Ask for What You Need

With the digitization of forms, you may be tempted to lengthen your questionnaire to include additional demographic information. After all, you’re no longer printing off the forms, saving time and paper. Resist the urge to add more questions. Brevity is key to keeping patients happy. Keep your intake forms limited to necessary details and save the additional questions for an optional follow-up survey you can send after their initial consultation to fill in at their own convenience.

5. Take It to the Treatment Room

 

If you’ve opted to eliminate the waiting area in your medical aesthetics clinic , prepare intake forms and have them waiting in the proper treatment rooms when your prospective patient arrives. Having this seamless process in place will give patients the impression that you and your staff value discretion and respect the patient’s time.

 

By instituting one or more of the above tips, you can improve the intake process for new clients and boost conversion rates through these positive experiences. For more information and insider tips on how to turn prospects into paying patients, download our eBook, “Mastering the Art of the Aesthetic Consult,” today!

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.